1 / 26

Marc Weeber 1,2 Grietje Molema 2

Literature-based Discovery in Biomedicine Five Potentially New Therapeutic Applications for Thalidomide. Marc Weeber 1,2 Grietje Molema 2. 1 National Library of Medicine, Bethesda, MD 2 Groningen University Institute for Drug Exploration, The Netherlands. Discovery Research in Groningen.

van
Télécharger la présentation

Marc Weeber 1,2 Grietje Molema 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Literature-based Discovery in BiomedicineFive Potentially New Therapeutic Applications for Thalidomide Marc Weeber1,2 Grietje Molema2 1National Library of Medicine, Bethesda, MD 2Groningen University Institute for Drug Exploration, The Netherlands

  2. Discovery Research in Groningen • Rein Vos, Drugs looking for diseases, 1991. Supervisor Theo Kuipers • Floor Rikken, Drugs in a different context, 1998. Supervisor Rein Vos • Marc Weeber, Literature-based discovery in biomedicine, 2001. Supervisors Rein Vos and Lolkje de Jong - van den Berg • Alexander van den Bosch, Rationality in discovery, 2001. Supervisors Theo Kuipers and Rein Vos

  3. Rationality in discovery • A study of logic, cognition, computation, and neuropharmacology, by Alexander van den Bosch. • a study of the concept of discovery, from the angles of logic, psychology and machine learning • a study of kinds of discoveries in the practice of neuropharmacology, distinguising different types of problems: searching for a good explanation, prediction or intervention. http://www.philos.rug.nl/~vdbosch/thesis-abstract.html for an abstract and a link to a preprint, hardcopies will be available in April.

  4. Introduction • Goal: Finding new biomedical scientific knowledge through the combination of existing knowledge as represented in the medical literature • Motivation: Prevention of re-inventing the wheel, re-usage of specific knowledge outside the original domain of discovery

  5. Swanson (I) Effects B Substance A Disease C

  6. Swanson (II) High blood viscosity Platelet aggregation Fish oil Raynaud’s disease

  7. Our Interests • Drugs instead of diet factors • Intermediate (B) terms may be adverse drug reactions • Drug – Adverse drug reactions – Disease: The DAD-system • Vos (1991) Drugs looking for diseases • Advanced Natural Language Processing (NLP) techniques

  8. Two-step Approach • Open discovery, generating a hypothesis A ?b ?c • Closed discovery, testing a hypothesis A ?b C

  9. Discovery Task • Replicating Swanson’s two famous literature-based discoveries: Weeber et al. 2001.JASIS 52(8) • Finding new applications for existing drugs

  10. Thalidomide • Introduced in early 60’s as a sedative • Withdrawn from market because of birth defects • In 1998: registered for use in leprosy patients • If after 40 years such a controversial drug has a new application, there might be more hidden knowledge for other applications

  11. Discovery Setting • Two human discoverers • information scientist • domain expert: immunologist/pharmacologist • Computer assisted text analysis • Computer output: biomedical concepts and sentences in which they occur (context) • Reading of relevant abstracts and full papers • Continuing reduction of possibilities

  12. Open Discovery: A B • 1,366 MEDLINE abstracts and titles • Selecting all immunologic factors results in 82 concepts. Most frequent ones: • Tumor necrosis factor • IL-2 • Cytokines • Antigens, CD4 • lymphocyte antigen CD69 • IL-12 • Antigens, CD5

  13. Why IL-12? • Expert vs. non-expert knowledge, IL-12 vs. TNF • Reasons: • IL-12 has recently been acknowledged an import immunologic role • IL-12 has not been researched as intensively as TNF • New knowledge not to be found in mainstream research

  14. Output for IL-12 • Inhibition of IL-12 production by thalidomide. • Thalidomide potentially suppressed the production of IL-12 by PBMC […]. • Thalidomide-induced inhibition of IL-12 production was additive […]. - - - - - - - - - - • Thalidomidestimulates […] IL-12 production in HIV patients.

  15. inhibition activation Th1/Th2 Differentation Th0 IL-12 IL-4, IL-6 Th1 Th2 IFN IL-2 IFN Lymphotoxin IL-4 IL-5 IL-10 IL-13 IL-4, IL-10 T-cell mediated autoimmune diseases Allergic diseases B cell activation

  16. inhibition activation Thalidomide and Th1/Th2 Thalidomide Th0 IL-12 IL-4, IL-6 Th1 Th2 IFN IL-2 IFN Lymphotoxin IL-4 IL-5 IL-10 IL-13 IL-4, IL-10 T-cell mediated autoimmune diseases Thalidomide Allergic diseases B cell activation

  17. Open Discovery: B C • 3,846 MEDLINE abstracts + titles on IL-12 • Selecting all diseases results in 420 concepts. 12 are selected: • Chronic hepatitis C • Sialadenitis • Myasthenia gravis • H. pylori-induced gastritis • Acute pancreatitis • Sjogren’s syndrome • Atherosclerosis • Pulmonary fibrosis • Brucellosis • Graves’ disease • Purpura • Chickenpox

  18. Selection Criteria • Already a small overlap between disease and thalidomide literature • NLP errors, e.g., number pi mapped to concept Pulmonary valve insufficiency • Some concepts are too broad, e.g., Critical illness • Some concepts are too specific, e.g., Salmonella infections • Some diseases benefit from increased IL-12

  19. Output Sentences: Diseases • IL-12 and […] expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis. • Possible involvement of IL-12expression by Epstein-Barr virus in Sjogren syndrome. • Acute pancreatitis patients had serum concentrations of total IL-12, IL-12p40, and IL-6 significantly higher (p < 0.05) than those of the healthy subjects. • Expression of B7-1, B7-2, and IL-12 in anti-Fas antibody-induced pulmonary fibrosis in mice.

  20. Closed Discovery: A B C • 70,000 titles and abstracts are analyzed • Focus on immunologic aspects • Several hundreds of sentences as final result • Final list of diseases: • Myasthenia gravis • Sialadenitis • Acute pancreatitis • Chronic hepatitis C • H. pyliory-induced gastritis

  21. Output Sialadenitis • These data argue for a major role of the proinflammatory cytokines […], IL- 12, IFN-gamma initiation and perpetuation of autoimmune sialoadenitis in MRL/lpr mice […] in conjunction with an insufficiency of the anti-inflammatory cytokines TGF-beta and IL-10. • Cells expressing tumour necrosis factor-alpha, […] and IL-12 mRNA were strongly up-regulated at about the time of onset of sialoadenitis […].

  22. Output, Chronic Hepatitis C • IL-12production in chronic hepatitis Cinfection. • Induction of IL-12production in chronic hepatitis C virus infection correlates with the hepatocellular damage. • In the current study, increased interferon-gamma, IL-10, and IL-12 p40 serum levels were observed in patients with chronic hepatitis C compared to controls.

  23. Use of Expert’s Knowledge • Anecdotal examples • Selecting IL-12 from the list • Potentially conflicting information concerning Myasthenia Gravis (Thalidomide in Lewis rats) • Different database: clinical experiment with thalidomide for Sjogren’s syndrome

  24. Discovery Support tool • Full automatic process not possible: • how to encode expert knowledge • principle: traversing all biomedical knowledge, unknown what expert knowledge is needed • NLP essential in filtering, but a complete formal representation of knowledge is not feasible • Full automatic process not desirable: • Guided search, not automatic mining (KDD) • Generation of hypotheses: not laws • Clinical relevance

  25. Future Perspectives • Better linguistic analysis • Different sources (e.g., annotated genetic databases) • Better user interface: Reduce work load for domain expert while minimizing role of information scientist • Far future: indirect or second order literature searching?

  26. Acknowledgments • Henny Klein (GUIDE) • Alan Aronson (NLM) • Jim Mork (NLM) • Rein Vos (Maastricht University) • Lolkje de Jong - van den Berg (GUIDE)

More Related